BlackRock reduces holdings of SINOPHARM (01099) by 1.564 million shares at a price of HK$17.357 per share.
On July 16th, BlackRock reduced its holdings in China National Pharmaceutical Group Corporation (01099) by 1,564,000 shares, with a price of HK$17.357 per share, totaling approximately HK$27.1463 million.
The latest data from the Hong Kong Stock Exchange shows that on July 16, BlackRock reduced its holdings of SINOPHARM (01099) by 1.564 million shares, at a price of 17.357 Hong Kong dollars per share, with a total amount of approximately 271.463 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 133 million shares, with the latest shareholding ratio of 9.91%.
Related Articles
US Stock Market Move | Stock prices continued to rise during the trading day! NVIDIA Corporation (NVDA.US) increased by nearly 3%.
OpenAI plans to invest over $30 billion in building an AI data center campus in Georgia, ramping up its global computing power layout.
MINIEYE (02431) plans to allocate up to 20,132,400 shares with a net fundraising of approximately HK$122 million.
US Stock Market Move | Stock prices continued to rise during the trading day! NVIDIA Corporation (NVDA.US) increased by nearly 3%.
OpenAI plans to invest over $30 billion in building an AI data center campus in Georgia, ramping up its global computing power layout.
MINIEYE (02431) plans to allocate up to 20,132,400 shares with a net fundraising of approximately HK$122 million.
RECOMMEND
